Literature DB >> 30584141

Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model.

Shawn M Barton1,2, Vaibhav A Janve1,2,3, Richard McClure1,2, Adam Anderson1,2,3, Joanne A Matsubara4, John C Gore1,2,3,5,6,7, Wellington Pham1,2,3,5,6,7,8.   

Abstract

The development of neurotherapeutics for many neurodegenerative diseases has largely been hindered by limited pharmacologic penetration across the blood-brain barrier (BBB). Previous attempts to target and clear amyloid-β (Aβ) plaques, a key mediator of neurodegenerative changes in Alzheimer's disease (AD), have had limited clinical success due to low bioavailability in the brain because of the BBB. Here we test the effects of inducing an inflammatory response to disrupt the BBB in the 5XFAD transgenic mouse model of AD. Lipopolysaccharide (LPS), a bacterial endotoxin recognized by the innate immune system, was injected at varying doses. 24 hours later, mice were injected with either thioflavin S, a fluorescent Aβ-binding small molecule or 30 nm superparamagnetic iron oxide (SPIO) nanoparticles, both of which are unable to penetrate the BBB under normal physiologic conditions. Our results showed that when pretreated with 3.0 mg/kg LPS, thioflavin S can be found in the brain bound to Aβ plaques in aged 5XFAD transgenic mice. Following the same LPS pretreatment, SPIO nanoparticles could also be found in the brain. However, when done on wild type or young 5XFAD mice, limited SPIO was detected. Our results suggest that the BBB in aged 5XFAD mouse model is susceptible to increased permeability mediated by LPS, allowing for improved delivery of the small molecule thioflavin S to target Aβ plaques and SPIO nanoparticles, which are significantly larger than antibodies used in clinical trials for immunotherapy of AD. Although this approach demonstrated efficacy for improved delivery to the brain, LPS treatment resulted in significant weight loss even at low doses, resulting from the induced inflammatory response. These findings suggest inducing inflammation can improve delivery of small and large materials to the brain for improved therapeutic or diagnostic efficacy. However, this approach must be balanced with the risks of systemic inflammation.

Entities:  

Keywords:  Alzheimer’s disease; blood-brain barrier; drug delivery; iron oxide nanoparticles; lipopolysaccharide

Mesh:

Substances:

Year:  2019        PMID: 30584141      PMCID: PMC9026569          DOI: 10.3233/JAD-180755

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.160


  63 in total

1.  Magnetic nanoparticles for imaging dendritic cells.

Authors:  Saho Kobukai; Richard Baheza; Jared G Cobb; Jack Virostko; Jingping Xie; Amelie Gillman; Dmitry Koktysh; Denny Kerns; Mark Does; John C Gore; Wellington Pham
Journal:  Magn Reson Med       Date:  2010-05       Impact factor: 4.668

Review 2.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 3.  Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier.

Authors:  Jason M Lajoie; Eric V Shusta
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-08       Impact factor: 13.820

4.  Electron microscopy of the effect of gram-negative endotoxin on the blood-brain barrier.

Authors:  C C Clawson; J F Hartmann; R L Vernier
Journal:  J Comp Neurol       Date:  1966-06       Impact factor: 3.215

Review 5.  Inflammation and Alzheimer's disease pathogenesis.

Authors:  J Rogers; S Webster; L F Lue; L Brachova; W H Civin; M Emmerling; B Shivers; D Walker; P McGeer
Journal:  Neurobiol Aging       Date:  1996 Sep-Oct       Impact factor: 4.673

6.  Lipopolysaccharide potentiates polychlorinated biphenyl-induced disruption of the blood-brain barrier via TLR4/IRF-3 signaling.

Authors:  Jeong June Choi; Yean Jung Choi; Lei Chen; Bei Zhang; Sung Yong Eum; Maria T Abreu; Michal Toborek
Journal:  Toxicology       Date:  2012-08-13       Impact factor: 4.221

Review 7.  Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex.

Authors:  Mitsuhiro Fujihara; Masashi Muroi; Ken-ichi Tanamoto; Tsuneo Suzuki; Hiroshi Azuma; Hisami Ikeda
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

8.  Myeloperoxidase-derived oxidants induce blood-brain barrier dysfunction in vitro and in vivo.

Authors:  Andreas Üllen; Evelin Singewald; Viktoria Konya; Günter Fauler; Helga Reicher; Christoph Nusshold; Astrid Hammer; Dagmar Kratky; Akos Heinemann; Peter Holzer; Ernst Malle; Wolfgang Sattler
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

9.  Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.

Authors:  William A Banks; Alicia M Gray; Michelle A Erickson; Therese S Salameh; Mamatha Damodarasamy; Nader Sheibani; James S Meabon; Emily E Wing; Yoichi Morofuji; David G Cook; May J Reed
Journal:  J Neuroinflammation       Date:  2015-11-25       Impact factor: 8.322

Review 10.  Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise.

Authors:  Christopher H van Dyck
Journal:  Biol Psychiatry       Date:  2017-08-24       Impact factor: 13.382

View more
  18 in total

1.  Aluminum-induced generation of lipopolysaccharide (LPS) from the human gastrointestinal (GI)-tract microbiome-resident Bacteroides fragilis.

Authors:  P N Alexandrov; J M Hill; Y Zhao; T Bond; C M Taylor; M E Percy; W Li; W J Lukiw
Journal:  J Inorg Biochem       Date:  2019-10-22       Impact factor: 4.155

2.  The Role of Gut Microbiota in Mice With Bile Duct Ligation-Evoked Cholestatic Liver Disease-Related Cognitive Dysfunction.

Authors:  Bowen Yang; Tianning Sun; Yingle Chen; Hongbing Xiang; Jun Xiong; Shiting Bao
Journal:  Front Microbiol       Date:  2022-05-10       Impact factor: 6.064

Review 3.  Use of Super Paramagnetic Iron Oxide Nanoparticles as Drug Carriers in Brain and Ear: State of the Art and Challenges.

Authors:  Caroline Guigou; Alain Lalande; Nadine Millot; Karim Belharet; Alexis Bozorg Grayeli
Journal:  Brain Sci       Date:  2021-03-11

Review 4.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

Review 5.  Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration.

Authors:  Carla Ribeiro Alvares Batista; Giovanni Freitas Gomes; Eduardo Candelario-Jalil; Bernd L Fiebich; Antonio Carlos Pinheiro de Oliveira
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

6.  Gastrointestinal (GI) Tract Microbiome-Derived Neurotoxins-Potent Neuro-Inflammatory Signals From the GI Tract via the Systemic Circulation Into the Brain.

Authors:  Walter J Lukiw
Journal:  Front Cell Infect Microbiol       Date:  2020-02-12       Impact factor: 5.293

7.  Pregabalin inhibits in vivo and in vitro cytokine secretion and attenuates spleen inflammation in Lipopolysaccharide/Concanavalin A -induced murine models of inflammation.

Authors:  Eman Y Abu-Rish; Ahmad T Mansour; Hebah T Mansour; Lina A Dahabiyeh; Shereen M Aleidi; Yasser Bustanji
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

8.  Ceramide analog [18F]F-HPA-12 detects sphingolipid disbalance in the brain of Alzheimer's disease transgenic mice by functioning as a metabolic probe.

Authors:  Simone M Crivelli; Daan van Kruining; Qian Luo; Jo A A Stevens; Caterina Giovagnoni; Andreas Paulus; Matthias Bauwens; Dusan Berkes; Helga E de Vries; Monique T Mulder; Jochen Walter; Etienne Waelkens; Rita Derua; Johannes V Swinnen; Jonas Dehairs; Felix M Mottaghy; Mario Losen; Erhard Bieberich; Pilar Martinez-Martinez
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

9.  Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (Aβ42) Peptide.

Authors:  Walter J Lukiw; Wenhong Li; Taylor Bond; Yuhai Zhao
Journal:  Front Cell Neurosci       Date:  2019-12-06       Impact factor: 5.505

10.  Inhalable Thioflavin S for the Detection of Amyloid Beta Deposits in the Retina.

Authors:  Shawn M Barton; Eleanor To; Baxter P Rogers; Clayton Whitmore; Manjosh Uppal; Joanne A Matsubara; Wellington Pham
Journal:  Molecules       Date:  2021-02-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.